1 L. Mulrane, "microRNAs : a new class of breast cancer biomarkers" 14 (14): 347-363, 2014
2 B. Zhou, "miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely" 104 (104): 7080-7085, 2007
3 F. Ramaekers, "Tissue distribution of keratin 7 as monitored by a monoclonal antibody" 170 (170): 235-249, 1987
4 B. M. Sibai, "Thrombophilia and severe preeclampsia : time to screen and treat in future pregnancies?" 46 (46): 1252-1253, 2005
5 I. Brosens, "The"Great Obstetrical Syndromes"are associated with disorders of deep placentation" 204 (204): 193-201, 2011
6 M. Halasz, "The role of progesterone in implantation and trophoblast invasion" 97 (97): 43-50, 2013
7 Y. He, "The role of miR-150 in normal and malignant hematopoiesis" 33 (33): 3887-3893, 2014
8 J. F. Mouillet, "The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction" 31 (31): 781-784, 2010
9 R. B. Donker, "The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes" 18 (18): 417-424, 2012
10 M. Cai, "Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications" 2017 : 6972732-, 2017
1 L. Mulrane, "microRNAs : a new class of breast cancer biomarkers" 14 (14): 347-363, 2014
2 B. Zhou, "miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely" 104 (104): 7080-7085, 2007
3 F. Ramaekers, "Tissue distribution of keratin 7 as monitored by a monoclonal antibody" 170 (170): 235-249, 1987
4 B. M. Sibai, "Thrombophilia and severe preeclampsia : time to screen and treat in future pregnancies?" 46 (46): 1252-1253, 2005
5 I. Brosens, "The"Great Obstetrical Syndromes"are associated with disorders of deep placentation" 204 (204): 193-201, 2011
6 M. Halasz, "The role of progesterone in implantation and trophoblast invasion" 97 (97): 43-50, 2013
7 Y. He, "The role of miR-150 in normal and malignant hematopoiesis" 33 (33): 3887-3893, 2014
8 J. F. Mouillet, "The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction" 31 (31): 781-784, 2010
9 R. B. Donker, "The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes" 18 (18): 417-424, 2012
10 M. Cai, "Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications" 2017 : 6972732-, 2017
11 B. H. Yoon, "Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes" 88 (88): 1034-1040, 1996
12 M. S. Ebert, "Roles for microRNAs in conferring robustness to biological processes" 149 (149): 515-524, 2012
13 A. Markou, "Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer" 49 (49): 1591-1603, 2011
14 C. W. Redman, "Preeclampsia : an excessive maternal inflammatory response to pregnancy" 180 (180): 499-506, 1999
15 V. Agarwal, "Predicting effective microRNA target sites in mammalian mRNAs" 4 : 2015
16 S. Lee, "Post-transcriptional stimulation of gene expression by microRNAs" 768 : 97-126, 2013
17 L. Ji, "Placental trophoblast cell differentiation : physiological regulation and pathological relevance to preeclampsia" 34 (34): 981-1023, 2013
18 E. N. Kim, "Placental deposition of C-reactive protein is a common feature of human pregnancy" 36 (36): 704-707, 2015
19 R. Romero, "Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae" 25 (25): 313-327, 2011
20 M. T. Gervasi, "Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia" 185 (185): 792-797, 2001
21 D. P. Bartel, "MicroRNAs: target recognition and regulatory functions" 136 (136): 215-233, 2009
22 M. Bidarimath, "MicroRNAs, immune cells and pregnancy" 11 (11): 538-547, 2014
23 R. Garzon, "MicroRNAs in normal and malignant hematopoiesis" 15 (15): 352-358, 2008
24 K. R. Bounds, "MicroRNAs : new players in the pathobiology of preeclampsia" 4 : 60-, 2017
25 K. Zhang, "MicroRNA-322 inhibits inflammatory cytokine expression and promotes cell proliferation in LPS-stimulated murine macrophages by targeting NF-κB1 (p50)" 37 (37): BSR2016023-, 2017
26 N. Luo, "MicroRNA-150 regulates lipid metabolism and inflammatory response" 2 (2): 2013
27 A. Chakrabarty, "MicroRNA regulation of cyclooxygenase-2 during embryo implantation" 104 (104): 15144-15149, 2007
28 S. Monticelli, "MicroRNA profiling of the murine hematopoietic system" 6 (6): R71-, 2005
29 L. Gan, "MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies" 96 (96): e7515-, 2017
30 C. Xiao, "MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb" 165 (165): 1027-, 2016
31 G. Sacks, "Maternal C‐reactive protein levels are raised at 4 weeks gestation" 19 (19): 1025-1030, 2004
32 P. Zhou, "Large-scale screens of miRNA-mRNA interactions unveiled that the 3'UTR of a gene is targeted by multiple miRNAs" 8 (8): e68204-, 2013
33 R. A. Howman, "Inflammatory and haematological markers in the maternal, umbilical cord and infant circulation in histological chorioamnionitis" 7 (7): e51836-, 2012
34 G. Ghosh, "Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis" 120 (120): 4141-4154, 2010
35 O. Genbacev, "Hypoxia alters early gestation human cytotrophoblast differentiation/ invasion in vitro and models the placental defects that occur in preeclampsia" 97 (97): 540-550, 1996
36 L. A. Cole, "Hyperglycosylated hCG, a review" 31 (31): 653-664, 2010
37 S. S. Luo, "Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes" 81 (81): 717-729, 2009
38 C. H. Graham, "Establishment and characterization of first trimester human trophoblast cells with extended lifespan" 206 (206): 204-211, 1993
39 D. M. Morales-Prieto, "Elsevier Trophoblast Research Award Lecture : origin, evolution and future of placenta miRNAs" 35 : S39-S45, 2014
40 E. Teran, "Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia" 75 (75): 243-249, 2001
41 E. R. Norwitz, "Defective implantation and placentation : laying the blueprint for pregnancy complications" 14 (14): 101-109, 2007
42 I. Kushner, "Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit" 148 (148): 466-477, 1978
43 B. P. Lewis, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets" 120 (120): 15-20, 2005
44 H. Schwarzenbach, "Clinical relevance of circulating cell-free microRNAs in cancer" 11 (11): 145-156, 2014
45 G. B. Hvilsom, "C-reactive protein : a serological marker for preterm delivery?" 81 (81): 424-429, 2002
46 S. Black, "C-reactive protein" 279 (279): 48487-48490, 2004
47 C. C. Pritchard, "Blood cell origin of circulating microRNAs : a cautionary note for cancer biomarker studies" 5 (5): 492-497, 2012
48 Y. Huang, "Biological functions of microRNAs : a review" 67 (67): 129-139, 2011
49 F. Mirzaie, "Association of maternal serum C-reactive protein levels with severity of preeclampsia" 293-296, 2009
50 C. W. Park, "An elevated maternal serum C-reactive protein in the context of intra-amniotic inflammation is an indicator that the development of amnionitis, an intense fetal and AF inflammatory response are likely in patients with preterm labor: clinical implications" 26 (26): 847-853, 2013
51 P. Sethupathy, "A guide through present computational approaches for the identification of mammalian microRNA targets" 3 (3): 881-886, 2006
52 R. Apps, "A critical look at HLA-G" 29 (29): 313-321, 2008